Live Breaking News & Updates on National expert group on vaccine administration

Stay updated with breaking news from National expert group on vaccine administration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

'No consensus among NTAGI members over administering additional shots'

An additional dose of a vaccine is different from a booster dose.

India , Lok-sabha , Mansukh-mandaviya , Union-health , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunization , Serum-institute-of-india , Health-ministry , World-health-organisation , National-technical-advisory-group , Serum-institute , Drug-regulator

Additional dose for immunocompromised? Panel meets today to take final call amid Omicron threat

Cancer patients on therapy, transplant patients, AIDS patients, among others, may be given a third dose of the vaccine to improve their protection.

India , Astrazeneca-chadox , Prakash-kumar-singh , Lok-sabha , Mansukh-mandaviya , Union-health , Regulatory-affairs , National-technical-advisory-group-on-immunisat , National-expert-group-on-vaccine-administration , Consortium-on-genomics , National-technical-advisory-group-on-immunization , National-technical-advisory-group-on-immunisation

'Need More Experiments': INSACOG Backtracks on Booster Dose Recommendation

The consortium of laboratories said it was merely discussing the role of booster doses and was not making a recommendation that the immunisation programme should include a third dose.

South-africa , New-delhi , Delhi , India , Genome-consortium , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunisation , National-technical-advisory-group , National-expert-group , Vaccine-administration ,

'Need More Experiments': INSACOG Backtracks on Booster Dose Recommendation

The consortium of laboratories said it was merely discussing the role of booster doses and was not making a recommendation that the immunisation programme should include a third dose.

South-africa , New-delhi , Delhi , India , Genome-consortium , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunisation , National-technical-advisory-group , National-expert-group , Vaccine-administration ,

Additional Dose For Those At Risk? Covid Panel NTAGI To Decide Tomorrow

The National Technical Advisory Group on Immunisation will meet tomorrow to NTAGI set to meet tomorrow to discuss the administration of additional doses of the Covid vaccine to immunocompromised individuals, officials said.

India , Astrazeneca-chadox , Prakash-kumar-singh , Lok-sabha , Mansukh-mandaviya , Union-health , Regulatory-affairs , National-expert-group-on-vaccine-administration , Consortium-on-genomics , Covid-panel-to-decide-tomorrow , National-technical-advisory-group-on-immunization , National-technical-advisory-group-on-immunisation

Does India need to rethink its vaccine strategy amid the Omicron threat?

States like Rajasthan, Chhattisgarh, Karnataka and Kerala have also urged the Central government for booster dose amid another variant of concern, Omicron.

Dombivli , Maharashtra , India , Karnataka , Delhi , Jamnagar , Gujarat , Chhattisgarh , Kerala , Rakesh-mishra , Manuskh-mandaviya , Lok-sabha

Govt considering scientific evidences on vaccination of kids in 12 to 17 yrs group, says MoS Health

Minister of State for Health Bharati Pravin Pawar said that the government is considering scientific evidences related to vaccination of children between the age group 12 to 17 years.

India , Bharat , Lok-sabha , National-expert-group , E-ltd , Johnson-pvt-ltd , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunization , Health-bharati-pravin-pawar , National-technical-advisory-group-on-immunisation , Vaccine-administration , National-technical-advisory-group

CDSCO Approves Shelf Life Of COVID-19 Vaccines

Responding to a question on the shelf life of Covid vaccines approved in the country and their active period among the vaccinated people, Mandaviya, in a written reply, said the vaccines were developed very recently, therefore, scientific evidence regarding the duration of protection is still evolving globally.

Bulandshahr , Uttar-pradesh , India , Mumbai , Maharashtra , Hyderabad , Andhra-pradesh , Bengaluru , Karnataka , Malur , Bharat-immunologicals , Lok-sabha

Govt considering scientific evidences on vaccination of kids in 12 to 17 yrs group: MoS Health

New Delhi: The National Expert Group on Vaccine Administration for COVID-19 and the National Technical Advisory Group on Immunisation are deliberating and considering scientific evidences related to vaccination...

India , New-delhi , Delhi , Bharat , Lok-sabha , National-expert-group , E-ltd , Johnson-pvt-ltd , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunization , Health-bharati-pravin-pawar , National-technical-advisory-group-on-immunisation

'Govt considering scientific evidences on vaccination of kids in 12 to 17 yrs group' | MorungExpress

New Delhi, December 3 (PTI): The National Expert Group on Vaccine Administration for COVID-19 and the National Technical Advisory Group on Immunisation are deliberating and considering scientific evidences related to vaccination of children between the ag

India , New-delhi , Delhi , Bharat , Lok-sabha , National-expert-group , E-ltd , Johnson-pvt-ltd , National-expert-group-on-vaccine-administration , National-technical-advisory-group-on-immunization , Health-bharati-pravin-pawar , National-technical-advisory-group-on-immunisation